Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25+0.04 (+3.31%)
Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%
Nkarta enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nkarta's enterprise value was -$72.94M on Nov 11, 2026, against -$142.68M a year earlier. Over the last 5 years it ranged from -$219.16M to $369.90M, with a median of -$103.56M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$72.94M | – |
| 2025 | Dec 31, 2025 | -$145.64M | – |
| 2024 | Dec 31, 2024 | -$129.40M | -372.2% |
| 2023 | Dec 29, 2023 | $47.53M | – |
| 2022 | Dec 30, 2022 | -$155.12M | -163.1% |
| 2021 | Dec 31, 2021 | $245.77M | -85.3% |
| 2020 | Dec 31, 2020 | $1.67B | – |
See a number that looks wrong?